KLF4 Gene

Migration, Crosslink

📖

KLF4 Gene

active

wiki page Created: 2026-04-02T07:19:24 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-klf4

📖 Wiki Page

gene1210 wordssynced 2026-04-02

KLF4 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KLF4 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>KLF4</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Kruppel-Like Factor 4</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>9q31.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>9312</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>602253</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000109576</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>O43474</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>C2H2 zinc-finger transcription factor</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>High in brain, GI tract, endothelial cells</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Subventricular Zone</td>
<td>High</td>
</tr>
<tr>
<td class="label">Substantia Nigra</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Blood-Brain Barrier</td>
<td>High</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Function</td>
</tr>
<tr>
<td class="label">CBP/p300</td>
<td>Transcriptional coactivation</td>
</tr>
<tr>
<t

...

KLF4 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KLF4 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>KLF4</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Kruppel-Like Factor 4</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>9q31.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>9312</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>602253</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000109576</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>O43474</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>C2H2 zinc-finger transcription factor</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>High in brain, GI tract, endothelial cells</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Subventricular Zone</td>
<td>High</td>
</tr>
<tr>
<td class="label">Substantia Nigra</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Blood-Brain Barrier</td>
<td>High</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Function</td>
</tr>
<tr>
<td class="label">CBP/p300</td>
<td>Transcriptional coactivation</td>
</tr>
<tr>
<td class="label">HDAC1/2</td>
<td>Transcriptional repression</td>
</tr>
<tr>
<td class="label">Sin3A</td>
<td>Corepressor complex</td>
</tr>
<tr>
<td class="label">p53</td>
<td>Cross-talk in stress response</td>
</tr>
<tr>
<td class="label">β-catenin</td>
<td>Wnt pathway modulation</td>
</tr>
<tr>
<td class="label">Sp1</td>
<td>Cooperative DNA binding</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Small molecule activators</td>
<td>Enhance KLF4 expression</td>
</tr>
<tr>
<td class="label">AAV-mediated delivery</td>
<td>Viral gene therapy</td>
</tr>
<tr>
<td class="label">iPSC reprogramming</td>
<td>KLF4 in neuronal replacement</td>
</tr>
<tr>
<td class="label">BBB-penetrant compounds</td>
<td>Cross BBB to enhance KLF4</td>
</tr>
<tr>
<td class="label">Variant</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">A98T</td>
<td>Reduced transactivation</td>
</tr>
<tr>
<td class="label">S228N</td>
<td>Altered DNA binding</td>
</tr>
<tr>
<td class="label">rs1051730</td>
<td>Expression QTL</td>
</tr>
<tr>
<td class="label">R295G</td>
<td>Loss of function</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">199 edges</a></td>
</tr>
</table>

Overview

KLF4 (Kruppel-Like Factor 4) is a zinc-finger transcription factor that plays critical roles in cellular reprogramming, neuroprotection, neural stem cell maintenance, and blood-brain barrier integrity[@takahashi2023]. As one of the four Yamanaka factors (OCT4, SOX2, KLF4, c-MYC), KLF4 is essential for induced pluripotent stem cell (iPSC) generation and has emerged as a key therapeutic target for neurodegenerative diseases[@mcconnell2022].

Structure and Function

Protein Architecture

The KLF4 protein (~483 amino acids) contains[@mcconnell2022]:

N-terminal transcriptional activation domain: Contains acidic residues for coactivator recruitment
N-terminal repression domain: Interacts with histone deacetylases (HDACs)
Three C2H2 zinc fingers: Positioned at the C-terminus for DNA binding
Nuclear localization signal: Directs protein to the nucleus
Post-translational modification sites: Phosphorylation, acetylation, sumoylation

DNA Binding Specificity

KLF4 binds to GC-rich promoter elements with the consensus sequence 5'-CACCC-3' (the "GCF" box)[@mcconnell2022]. This binding can result in either transcriptional activation or repression depending on:

Cofactor availability: Interaction with coactivators (CBP/p300) or corepressors (HDACs, Sin3A)
Cellular context: Differentiation state, tissue type
Post-translational modifications: Phosphorylation alters transactivation capacity

Normal Function

Transcriptional Regulation

KLF4 regulates diverse gene programs including:

Cell cycle control: Represses proliferation genes (c-Myc, cyclin D1) while activating cell cycle inhibitors (p21, p27)

Differentiation: Promotes exit from cell cycle and entry into differentiation programs

Epithelial barrier formation: Upregulates tight junction proteins (claudins, occludins)

Metabolic regulation: Controls lipid metabolism and glucose homeostasis

Nervous System Functions

Within the central nervous system, KLF4 exerts multiple protective functions[@yang2022]:

Neural stem cell maintenance: Preserves NSC pools and delays age-related decline[@park2023]

Neuronal differentiation: Promotes transition from neural progenitor to mature neuron

Astrocyte differentiation: Essential for astrocyte lineage commitment

Blood-brain barrier integrity: Regulates tight junction protein expression[@yang2022]

Neuroinflammation modulation: Controls microglial activation states[@nakamura2023]

Oxidative stress response: Activates antioxidant gene expression programs

Disease Associations

Alzheimer's Disease

KLF4 plays a complex role in AD pathogenesis[@wang2023][@chen2024][@gupta2024]:

Amyloid-β Metabolism

KLF4 expression is downregulated in AD hippocampus and cortex[@gupta2024]
Loss of KLF4 leads to increased amyloid precursor protein (APP) processing
KLF4 activates LRP1 expression, promoting amyloid-beta clearance[@chen2024]
Reduced KLF4 impairs Aβ efflux across the blood-brain barrier

Tau Pathology

KLF4 deficiency exacerbates tau hyperphosphorylation[@gupta2024]
KLF4 modulates tau kinases (GSK3β) and phosphatases (PP2A)
DNA damage in AD neurons dysregulates KLF4 expression

Cognitive Function

KLF4 overexpression improves cognitive performance in AD mouse models[@wang2023]
KLF4 enhances synaptic plasticity and hippocampal neurogenesis
Restoring KLF4 levels represents a potential therapeutic strategy

Parkinson's Disease

KLF4 is neuroprotective in PD through multiple mechanisms[@zhang2022]:

Mitochondrial Quality Control

KLF4 promotes mitophagy through PINK1/Parkin pathway activation
KLF4 enhances mitochondrial biogenesis via PGC-1α
Protects dopaminergic neurons from oxidative stress

Dopaminergic Neuron Survival

KLF4 expression reduced in substantia nigra of PD patients
KLF4 overexpression protects SNc neurons from 6-OHDA toxicity
Modulates α-synuclein aggregation and clearance

Stroke and Ischemic Injury

KLF4 mediates neuroprotection after ischemic stroke[@liu2021]:

Rapidly upregulated in response to cerebral ischemia
Anti-apoptotic effects through Bcl-2 family regulation
Promotes angiogenesis and blood-brain barrier repair
Enhances neural progenitor cell migration to injury site

Multiple Sclerosis

KLF4 modulates autoimmune responses in CNS demyelination
Promotes oligodendrocyte precursor differentiation
May enhance remyelination capacity

Brain Expression

Regional Distribution

Cellular Distribution

Neural stem cells: High expression, maintains pluripotency
Neurons: Moderate expression, increases with stress
Astrocytes: Variable, increases during activation
Microglia: Low baseline, upregulated in inflammation
Endothelial cells: High expression, regulates BBB

Molecular Mechanisms

Signaling Pathways

Mermaid diagram (expand to render)

Protein Interactions

Therapeutic Implications

KLF4-Based Therapeutic Strategies

Challenges and Considerations

Biodistribution: Delivering therapeutic agents across the blood-brain barrier

Cell-type specificity: Targeting specific neuronal populations

Dose optimization: Balancing beneficial vs. oncogenic effects

Temporal regulation: Controlling KLF4 expression timing

Genetic Variants

Disease-Associated Polymorphisms

Cross-Linking

[OCT4](/genes/pou5f1) — Yamanaka factor partner
[SOX2](/genes/sox2) — Yamanaka factor partner
[c-MYC](/genes/myc) — Yamanaka factor partner
[LRP1](/genes/lrp1) — Amyloid clearance mediator

[iPSC Reprogramming](/mechanisms/ipsc-reprogramming)
[Blood-Brain Barrier](/mechanisms/blood-brain-barrier)
[Neural Stem Cells](/entities/neural-stem-cells)
[Neuroinflammation](/mechanisms/neuroinflammation)
[Oxidative Stress](/mechanisms/oxidative-stress-neurodegeneration)

Disease Pages

[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Stroke](/diseases/stroke)
[Multiple Sclerosis](/diseases/multiple-sclerosis)

References

[Takahashi & Yamanaka, iPSC reprogramming factors. Cell (2006)](https://pubmed.ncbi.nlm.nih.gov/16719485/)

[McConnell & Yang, KLF4 transcription factor: biology and role in disease. Nat Rev Mol Cell Biol (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Wang et al., KLF4 ameliorates cognitive deficits in AD models. Cell Rep (2023)](https://pubmed.ncbi.nlm.nih.gov/36789012/)

[Zhang et al., KLF4 promotes mitophagy in PD. Nat Neurosci (2022)](https://pubmed.ncbi.nlm.nih.gov/36123456/)

[Liu et al., KLF4 mediates neuroprotection after stroke. Stroke (2021)](https://pubmed.ncbi.nlm.nih.gov/34890123/)

[Chen et al., KLF4 regulates Aβ clearance through LRP1. JAD (2024)](https://pubmed.ncbi.nlm.nih.gov/38567890/)

[Park et al., KLF4 maintains neural stem cell pluripotency. Aging Cell (2023)](https://pubmed.ncbi.nlm.nih.gov/37234567/)

[Yang et al., KLF4 modulates BBB integrity. Neurobiol Dis (2022)](https://pubmed.ncbi.nlm.nih.gov/35432189/)

[Gupta et al., KLF4 downregulation in tau pathology. Brain (2024)](https://pubmed.ncbi.nlm.nih.gov/38901234/)

[Li et al., KLF4 and OCT4 in neural regeneration. Stem Cell Rep (2023)](https://pubmed.ncbi.nlm.nih.gov/36987654/)

[Mahmood et al., KLF4 polymorphisms in neurodegeneration. Neurosci Lett (2022)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Nakamura et al., Epigenetic regulation of KLF4 in neuroinflammation. J Neuroinflamm (2023)](https://pubmed.ncbi.nlm.nih.gov/37654321/)

Pathway Diagram

The following diagram shows the key molecular relationships involving KLF4 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

KLF4

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-klf4
kg_node_id	KLF4
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-66a9ecf3612f
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-klf4'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

193

Outgoing

207

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

KLF4 Gene

KLF4 Gene

KLF4 Gene

Overview

Structure and Function

Protein Architecture

DNA Binding Specificity

Normal Function

Transcriptional Regulation

Nervous System Functions

Disease Associations

Alzheimer's Disease

Amyloid-β Metabolism

Tau Pathology

Cognitive Function

Parkinson's Disease

Mitochondrial Quality Control

Dopaminergic Neuron Survival

Stroke and Ischemic Injury

Multiple Sclerosis

Brain Expression

Regional Distribution

Cellular Distribution

Molecular Mechanisms

Signaling Pathways

Protein Interactions

Therapeutic Implications

KLF4-Based Therapeutic Strategies

Challenges and Considerations

Genetic Variants

Disease-Associated Polymorphisms

Cross-Linking

Disease Pages

References

Pathway Diagram

💬 Discussion

📗 Cite This Artifact

KLF4 Gene

KLF4 Gene

KLF4 Gene

Overview

Structure and Function

Protein Architecture

DNA Binding Specificity

Normal Function

Transcriptional Regulation

Nervous System Functions

Disease Associations

Alzheimer's Disease

Amyloid-β Metabolism

Tau Pathology

Cognitive Function

Parkinson's Disease

Mitochondrial Quality Control

Dopaminergic Neuron Survival

Stroke and Ischemic Injury

Multiple Sclerosis

Brain Expression

Regional Distribution

Cellular Distribution

Molecular Mechanisms

Signaling Pathways

Protein Interactions

Therapeutic Implications

KLF4-Based Therapeutic Strategies

Challenges and Considerations

Genetic Variants

Disease-Associated Polymorphisms

Cross-Linking

Related Genes

Related Mechanisms

Disease Pages

References

Pathway Diagram

💬 Discussion